CSI Market
Sign In | Register

Akero Therapeutics Inc (AKRO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AKRO Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Akero Therapeutics Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent176.03
Marketable Securities, Current SH561.79
Cash & Short-term Investments737.00
Prepaid Expense And Other Assets Current16.71
Total Current Assets754.54
Equipment/Property/Plant Net0.00
Long-term investments250.49
Other Assets, Noncurrent1.00
Operating Lease Right Of Use Asset0.55
Total Assets1,005.58
Liabilities
Accounts Payable, Current AC20.40
Other Liabilities, Current27.25
Total Current Liabilities47.65
Long-term debt0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent0.29
Accrued Expenses And Other Current Liabilities27.25
Operating Lease Liability Noncurrent0.29
Total Liabilities47.94
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock2,004.76
Retained Earnings / Accumulated Deficit-1,048.95
Other Equity1.83
Common Stockholder's Equity957.64
Total Stockholder's Equity957.64
Liabilities & Stockholder's Equity1,005.58
4 historic quarters locked

Sign in to unlock the full Akero Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Akero Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-272569

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.